V Wealth Advisors LLC Crispr Therapeutics Ag Transaction History

V Wealth Advisors LLC

  • $123 Million
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 17, 2022
SELL
$70.09 - $111.29 $138,427 - $219,797
-1,975 Closed
0 $0
Q2 2021

Jul 27, 2021
BUY
$100.84 - $161.89 $20,168 - $32,377
200 Added 11.27%
1,975 $318,000
Q1 2021

Apr 20, 2021
BUY
$110.72 - $210.04 $11,072 - $21,004
100 Added 5.97%
1,775 $216,000
Q4 2020

Jan 25, 2021
BUY
$79.67 - $173.23 $133,447 - $290,160
1,675 New
1,675 $256,000

Others Institutions Holding CRSP

# of Institutions
488
Shares Held
64.1M
Call Options Held
1.64M
Put Options Held
1.93M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.2B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track V Wealth Advisors LLC Portfolio

Follow V Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of V Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on V Wealth Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email